A combined team of medical researchers from Columbia University and the University of Michigan has found that, despite multiple mutations, the SARS-CoV-2 omicron subvariant BA.2.86 does not appear to be more dangerous than ...
Clostridioides difficile (C. diff) intestinal infections can cause severe, debilitating diarrhea in patients who are hospitalized or on immunosuppressive therapies. The infections can be very hard to eradicate, roaring back ...
Oct 26, 2023
0
21
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of which is guided by biomarker testing.
Oct 18, 2023
0
0
A team of researchers investigating the transmission of HIV have discovered that HIV antibodies provide sterilizing immunity by inhibiting the infection of the first cell. The research is published in the journal Cell Reports ...
Oct 12, 2023
0
24
A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor ...
Oct 12, 2023
0
38
For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...
Oct 5, 2023
0
1
Research led by the University of Tübingen, Germany, along with partners at Stanford University, Emory University and the Cincinnati Children's Hospital Medical Center, U.S., has looked into infant immune responses following ...
If you've been diagnosed with high blood pressure, you're in good company. Nearly half of the adults in the U.S. have high blood pressure, and many don't even know they have it, according to the American Heart Association.
Oct 3, 2023
0
9
Researchers at Karolinska Institutet who studied SARS-CoV-2 variant BA.2.86, found that the new variant was not significantly more resistant to antibodies than several other variants that are circulating. The study also showed ...
Oct 2, 2023
0
30
